Paper15599747
Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.
Woodfield JC and 4 others. World J Surg, 2005. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery. Papers, record 15599747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/15599747
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Using cost of infection as a tool to demonstrate a difference in prophylactic antibiotic efficacy: a prospective randomized comparison of the pharmacoeconomic effectiveness of ceftriaxone and cefotaxime prophylaxis in abdominal surgery.
- PubMed
- Publication types
- Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Antibiotic Prophylaxis | Major topic |
| Cefotaxime | Major topic |
| Ceftriaxone | Major topic |
| Digestive System Surgical Procedures | Major topic |
| Surgical Wound Infection | Major topic |
| Aged | |
| Cost of Illness | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Randomized Controlled Trials as Topic | |
| Treatment Outcome | |
| Urinary Tract Infections |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 16485064 | To the editor: Surgical infection nomenclature. | https://conductscience.org/library/papers/16485064 |
Source PubMed
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3501976 | Comparative antimicrobial activity of aminothiazolyl methoxyimino cephalosporins against anaerobic bacteria, including 100 cefoxitin-resistant isolates. | Diagn Microbiol Infect Dis | 1987 | https://conductscience.org/library/papers/3501976 | PubMed |
| 2 | 8521766 | Drug utilisation review (DUR) of the third generation cephalosporins. Focus on ceftriaxone, ceftazidime and cefotaxime. | Drugs | 1995 | https://conductscience.org/library/papers/8521766 | PubMed |
| 3 | 10030811 | Surgical wound infection surveillance: the importance of infections that develop after hospital discharge. | Aust N Z J Surg | 1999 | https://conductscience.org/library/papers/10030811 | PubMed |
| 4 | 10163416 | Cost-effective prophylaxis of surgical infections. | Pharmacoeconomics | 1996 | https://conductscience.org/library/papers/10163416 | PubMed |
| 5 | 10163628 | Approaches to rationing drugs in hospitals. An Australian perspective. | Pharmacoeconomics | 1996 | https://conductscience.org/library/papers/10163628 | PubMed |
| 6 | 10580621 | The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. | Infect Control Hosp Epidemiol | 1999 | https://conductscience.org/library/papers/10580621 | PubMed |
| 7 | 2868173 | A scoring method (ASEPSIS) for postoperative wound infections for use in clinical trials of antibiotic prophylaxis. | Lancet | 1986 | https://conductscience.org/library/papers/2868173 | PubMed |
| 8 | 3145014 | Cost-benefit analysis of cephradine and mezlocillin prophylaxis for abdominal and vaginal hysterectomy. | Br J Obstet Gynaecol | 1988 | https://conductscience.org/library/papers/3145014 | PubMed |
| 9 | 4014250 | Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions. | Am J Hosp Pharm | 1985 | https://conductscience.org/library/papers/4014250 | PubMed |
| 10 | 8179082 | Effectiveness of ceftriaxone versus cefoxitin in reducing chest and wound infections after upper abdominal operations. | Am J Surg | 1994 | https://conductscience.org/library/papers/8179082 | PubMed |
| 11 | 7907621 | The cost of infection in surgical patients: a case-control study. | J Hosp Infect | 1993 | https://conductscience.org/library/papers/7907621 | PubMed |
| 12 | 3150661 | Cost-efficiency of a long-acting cephalosporin agent. | Aust N Z J Surg | 1988 | https://conductscience.org/library/papers/3150661 | PubMed |
| 13 | 8078149 | Clinical decision making: from theory to practice. Rationing resources while improving quality. How to get more for less. | JAMA | 1994 | https://conductscience.org/library/papers/8078149 | PubMed |
| 14 | 8678775 | A cost-effectiveness evaluation of 3 antimicrobial regimens for the prevention of infective complications after abdominal surgery. | Arch Surg | 1996 | https://conductscience.org/library/papers/8678775 | PubMed |
| 15 | 3927017 | Cost containment and the physician. | JAMA | 1985 | https://conductscience.org/library/papers/3927017 | PubMed |
| 16 | 7457491 | Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. | Am J Med | 1981 | https://conductscience.org/library/papers/7457491 | PubMed |
| 17 | 3264121 | Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. | Am J Infect Control | 1988 | https://conductscience.org/library/papers/3264121 | PubMed |
| 18 | 8127505 | Hospital drug therapy cost containment through a preferred medicines list and drug utilisation review system. | N Z Med J | 1994 | https://conductscience.org/library/papers/8127505 | PubMed |
| 19 | 10160478 | Statistical analysis in pharmacoeconomic studies. A review of current issues and standards. | Pharmacoeconomics | 1996 | https://conductscience.org/library/papers/10160478 | PubMed |
| 20 | 1824793 | The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. | N Engl J Med | 1991 | https://conductscience.org/library/papers/1824793 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40444666 | The Impact of Metachronous Colorectal Neoplasia Requiring Surgery After Cessation of Colonoscopic Surveillance at Age 75. | ANZ J Surg | 2025 | https://conductscience.org/library/papers/40444666 | PubMed |
| 38481245 | The role of antimicrobial prophylaxis in laparoscopic nephrectomy for renal cell carcinoma. | BMC Urol | 2024 | https://conductscience.org/library/papers/38481245 | PubMed |
| 19649758 | A meta-analysis of randomized, controlled trials assessing the prophylactic use of ceftriaxone. A study of wound, chest, and urinary infections. | World J Surg | 2009 | https://conductscience.org/library/papers/19649758 | PubMed |
| 16485064 | To the editor: Surgical infection nomenclature. | World J Surg | 2006 | https://conductscience.org/library/papers/16485064 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/15599747
GET https://conductscience.org/api/papers/v1/15599747/references?page=2